Nasdaq to Suspend Synergy CHC Trading September 18 After Bankruptcy Delisting
SNYR has more than doubled off its 52-week low of $0.068 on elevated volume (36× avg).
Summary
Nasdaq will suspend trading in Synergy CHC Corp. shares on September 18, 2026, after determining the company's securities should be delisted following its Chapter 11 bankruptcy filing. The company does not plan to appeal.
Key Events · Legal and Risk Events · SNYR
-
Nasdaq Delisting Determination
Nasdaq staff determined Synergy CHC's securities will be delisted under Listing Rules 5101, 5110(b), and IM-5101-1, citing the Chapter 11 bankruptcy filing, public interest concerns, residual equity interest concerns, and sustainability of listing compliance.
-
Trading Suspension September 18
Trading of SNYR common stock will be suspended at the opening of business on September 18, 2026, and a Form 25-NSE will be filed with the SEC to remove the securities from Nasdaq listing.
-
No Appeal Planned
The company does not presently intend to appeal Nasdaq's determination, making the delisting effectively final.
-
Bankruptcy Context
This delisting follows the company's voluntary Chapter 11 filing on September 4, 2026, which itself came after Costco discontinued FOCUSfactor products, a defaulted $17.6 million term loan, and lender acceleration of the full $18.9 million balance.
Analysis · SNYR · Life Sciences
Nasdaq has determined to delist Synergy CHC Corp. following its Chapter 11 bankruptcy filing, citing public interest concerns, residual equity interest concerns, and sustainability of listing compliance. Trading will be suspended at the open on September 18, 2026, and the company does not intend to appeal. This is a terminal event for the stock's exchange listing and follows a cascade of distress: Costco discontinuing FOCUSfactor products, a defaulted $17.6 million term loan, lender acceleration, and the bankruptcy filing itself. For existing shareholders, the delisting removes the last liquid trading venue and signals that the residual equity is likely to be wiped out in bankruptcy.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 40.2% of the 383 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.55%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SNYR was trading at $0.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $0.07 to $2.96. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.